NYSE:MCK
McKesson Corp (MCK)
Financials 
Technical Analysis 
Jun 7, 2026, 12:00 amThis summary was created by AI, based on 9 opinions in the last 12 months.
McKesson Corp (MCK-N) is recognized as a leading player in the pharmaceutical logistics sector, highlighting its significant role as the largest distributor of drugs in the U.S. The company benefits from demographic trends that favor consistent demand for prescription medications, evidenced by a high percentage of Americans reliant on daily prescriptions. Recent expert reviews note a promising earnings growth potential of 12-13%, even as the stock trades below its 200-day moving average, raising some concerns. The firm is expected to spin off its medical/surgical unit, which could unveil additional value for investors. Overall, analysts appreciate the company's stable performance, strong return on invested capital, and historical dividend growth, despite the sector's recent rotation away from healthcare.
Kyle McKay
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
